Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 11

1.

Dimerization of human uridine diphosphate glucuronosyltransferase allozymes 1A1 and 1A9 alters their quercetin glucuronidation activities.

Liu YQ, Yuan LM, Gao ZZ, Xiao YS, Sun HY, Yu LS, Zeng S.

Sci Rep. 2016 Mar 30;6:23763. doi: 10.1038/srep23763.

2.

UGT1A1 gene mutation due to Crigler-Najjar syndrome in Iranian patients: identification of a novel mutation.

Mohammadi Asl J, Tabatabaiefar MA, Galehdari H, Riahi K, Masbi MH, Zargar Shoshtari Z, Rahim F.

Biomed Res Int. 2013;2013:342371. doi: 10.1155/2013/342371. Epub 2013 Oct 28.

3.

Prediction of deleterious non-synonymous single-nucleotide polymorphisms of human uridine diphosphate glucuronosyltransferase genes.

Di YM, Chan E, Wei MQ, Liu JP, Zhou SF.

AAPS J. 2009 Sep;11(3):469-80. doi: 10.1208/s12248-009-9126-z. Epub 2009 Jul 2.

4.

Role of cysteine residues in the function of human UDP glucuronosyltransferase isoform 1A1 (UGT1A1).

Ghosh SS, Lu Y, Lee SW, Wang X, Guha C, Roy-Chowdhury J, Roy-Chowdhury N.

Biochem J. 2005 Dec 15;392(Pt 3):685-92.

5.

Molecular biology and the diagnosis and treatment of liver diseases.

Worman HJ, Feng L, Mamiya N.

World J Gastroenterol. 1998 Jun;4(3):185-191. No abstract available.

6.

Splice-site mutations: a novel genetic mechanism of Crigler-Najjar syndrome type 1.

Gantla S, Bakker CT, Deocharan B, Thummala NR, Zweiner J, Sinaasappel M, Roy Chowdhury J, Bosma PJ, Roy Chowdhury N.

Am J Hum Genet. 1998 Mar;62(3):585-92.

8.

The use of jejunal transplants to treat a genetic enzyme deficiency.

Jaffe BM, Burgos AA, Martinez-Noack M.

Ann Surg. 1996 Jun;223(6):649-56; discussion 656-7.

10.

Discrimination between Crigler-Najjar type I and II by expression of mutant bilirubin uridine diphosphate-glucuronosyltransferase.

Seppen J, Bosma PJ, Goldhoorn BG, Bakker CT, Chowdhury JR, Chowdhury NR, Jansen PL, Oude Elferink RP.

J Clin Invest. 1994 Dec;94(6):2385-91.

11.

Supplemental Content

Support Center